Skip to Content

Label Changes for:

Intelence (etravirine) 100 mg tablets

February 2010

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2010


Table 3: Established and Other Potentially Significant Drug Interactions: Alterations in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted Interaction

the following drug interactions were updated in the table:

  • between etravirine and fluconazole 
  • voriconazole 
  • lopinavir/ritonavir and 
  • clopidogrel 
  • and to include information on coadministration of protease inhibitors with or without ritonavir